| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
tumor protein p53 | 0.236 | 0.962 | 0.53 |
|
group | 0.400 | None | 0.945 | 711 | 7 | 1990 | 2020 | ||||||||
|
erb-b2 receptor tyrosine kinase 2 | 0.328 | 0.923 | 6.0E-03 |
|
group | 0.100 | None | 0.948 | 307 | 2 | 1989 | 2020 | ||||||||
|
epidermal growth factor receptor | 0.295 | 0.885 | 0.37 |
|
group | 0.400 | None | 0.976 | 206 | 3 | 1988 | 2020 | ||||||||
|
cyclin dependent kinase inhibitor 2A | 0.300 | 0.885 | 0.39 |
|
group | 0.100 | None | 0.959 | 196 | 2 | 1995 | 2020 | ||||||||
|
KRAS proto-oncogene, GTPase | 0.320 | 0.923 | 7.9E-04 |
|
group | 0.400 | None | 0.969 | 130 | 1 | 1984 | 2020 | ||||||||
|
catenin beta 1 | 0.303 | 0.885 | 1.00 |
|
group | 0.100 | None | 0.963 | 109 | 3 | 1997 | 2020 | ||||||||
|
B-Raf proto-oncogene, serine/threonine kinase | 0.319 | 0.846 | 1.00 |
|
group | 0.100 | None | 0.968 | 93 | 2 | 2003 | 2019 | ||||||||
|
H3 histone pseudogene 10 | 0.350 | 0.846 |
|
group | 0.100 | None | 0.933 | 90 | 0 | 1995 | 2020 | |||||||||
|
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha | 0.292 | 0.923 | 1.00 |
|
group | 0.100 | None | 0.975 | 81 | 3 | 2001 | 2020 | ||||||||
|
BRCA1 DNA repair associated | 0.367 | 0.923 | 9.2E-29 |
|
group | 0.400 | None | 0.975 | 81 | 0 | 1996 | 2020 | ||||||||
|
cyclin D1 | 0.344 | 0.923 | 0.89 |
|
group | 0.400 | None | 0.962 | 79 | 0 | 1990 | 2019 | ||||||||
|
BCL2 apoptosis regulator | 0.291 | 0.885 | 0.56 |
|
group | 0.400 | None | 0.911 | 79 | 0 | 1994 | 2018 | ||||||||
|
mutL homolog 1 | 0.399 | 0.808 | 3.4E-05 |
|
group | 0.200 | None | 0.973 | 75 | 4 | 1996 | 2017 | ||||||||
|
estrogen receptor 1 | 0.324 | 0.962 | 1.00 |
|
group | 0.400 | None | 0.957 | 70 | 4 | 1982 | 2019 | ||||||||
|
APC regulator of WNT signaling pathway | 0.373 | 0.962 | 1.00 |
|
group | 0.200 | None | 0.969 | 65 | 5 | 1990 | 2018 | ||||||||
|
mucin 1, cell surface associated | 0.384 | 0.885 | 1.9E-02 |
|
group | 0.100 | None | 0.968 | 62 | 0 | 1991 | 2019 | ||||||||
|
phosphatase and tensin homolog | 0.305 | 0.923 | 0.26 |
|
group | 0.500 | None | 0.867 | 60 | 0 | 1997 | 2019 | ||||||||
|
prostaglandin-endoperoxide synthase 2 | 0.314 | 0.962 | 1.00 |
|
group | 0.400 | None | 0.982 | 57 | 0 | 1994 | 2019 | ||||||||
|
SMAD family member 4 | 0.401 | 0.808 | 1.00 |
|
group | 0.100 | None | 0.982 | 55 | 0 | 1996 | 2019 | ||||||||
|
HRas proto-oncogene, GTPase | 0.378 | 0.885 | 8.0E-02 |
|
group | 0.400 | None | 0.962 | 52 | 2 | 1983 | 2019 | ||||||||
|
vascular endothelial growth factor A | 0.266 | 0.923 | 2.4E-05 |
|
group | 0.100 | None | 0.939 | 49 | 0 | 1995 | 2019 | ||||||||
|
MET proto-oncogene, receptor tyrosine kinase | 0.380 | 0.846 | 0.97 |
|
group | 0.400 | None | 0.958 | 48 | 7 | 1991 | 2019 | ||||||||
|
cadherin 1 | 0.401 | 0.808 | 0.15 |
|
group | 0.400 | None | 1.000 | 47 | 0 | 1994 | 2019 | ||||||||
|
CD274 molecule | 0.324 | 0.923 | 1.9E-02 |
|
group | 0.100 | None | 1.000 | 46 | 0 | 2014 | 2019 | ||||||||
|
CD44 molecule (Indian blood group) | 0.363 | 0.962 | 2.4E-07 |
|
group | 0.100 | None | 0.978 | 45 | 0 | 1991 | 2019 |